A recent international survey presented at the ESC Cardio-Oncology 2026 conference reveals significant gaps in cardio-oncology training among healthcare professionals. The study, conducted by the Cardio-Oncologists Of tomorrow Leaders (COOL) group, identifies a critical need for standardized education to manage the cardiovascular risks associated with modern cancer treatments.
Why is specialized cardio-oncology training becoming a priority?
Modern cancer therapies allow patients to live longer, but these treatments often cause cardiovascular toxicity. According to the European Society of Cardiology (ESC), the field of cardio-oncology focuses on optimizing cancer care while minimizing damage to the heart. As cancer survivorship rates increase, the medical community faces a growing number of patients dealing with long-term cardiac side effects from chemotherapy and other therapies.
To address these emerging risks, the ESC established the Council of Cardio-Oncology and published expert-led guidelines in 2022. These guidelines provide a framework for clinicians, yet the recent survey suggests that the practical application of this knowledge remains inconsistent due to educational deficits.
What did the COOL group survey reveal about current education?
The survey identified a lack of comprehensive training spanning from medical school through postgraduate specialization. Dr. Massimiliano Camilli from the Policlinico Universitario Agostino Gemelli, IRCCS, in Rome, stated the COOL group launched this study to understand the specific educational needs of professionals across Europe and beyond.
The research utilized an anonymized, web-based survey to gather data from a global cohort. Key findings from the study include:
- Global Reach: 398 respondents participated from 63 different countries.
- Professional Composition: 73% of the respondents were board-certified cardiologists.
- Target Demographic: The survey included cardiologists, cardiology residents, and other healthcare professionals treating cancer patients.
The data suggests that while specialists are actively treating these patients, the formal training required to manage complex cardio-oncology cases isn’t yet standardized across the medical curriculum.
How will the field evolve to address these training gaps?
The findings at ESC Cardio-Oncology 2026 suggest a shift toward more integrated, multidisciplinary educational models. The COOL group, which was created within the ESC Council to engage the next generation of specialists, is currently developing educational strategies to meet these evolving needs. Future medical curricula will likely include specific modules on cardiotoxicity to ensure that both oncologists and cardiologists can collaborate effectively.
As treatment protocols for cancer continue to advance, the integration of cardiac monitoring will become a standard part of oncology care. This evolution aims to bridge the gap between specialties, ensuring that life-saving cancer treatments don’t come at the cost of long-term heart health.
Frequently Asked Questions
What is cardio-oncology?
Cardio-oncology is a medical specialty that focuses on managing the cardiovascular risks and side effects associated with cancer treatments.
Who conducted the recent cardio-oncology survey?
The survey was conducted by the Cardio-Oncologists Of tomorrow Leaders (COOL) group, which operates under the ESC Council of Cardio-Oncology.
Why is heart health important for cancer patients?
Many cancer therapies can cause toxicity to the heart muscle, potentially leading to long-term cardiovascular issues if not properly monitored and managed.
What do you think is the most important step in improving specialist training? Let us know your thoughts in the comments below, or subscribe to our newsletter for the latest updates in medical research.
